Skip to content

Opening book details…

About this Medicine article

Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na–K-ATPase inhibition: a new promising treatment for acute heart failure syndromes? by Hashim Khan; Marco Metra; John E. A. Blair; Mark Vogel; Matthew E. Harinstein; Gerasimos S. Filippatos; Hani N. Sabbah; Herve Porchet; Giovanni Valentini; Mihai Gheorghiade is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Hashim Khan; Marco Metra; John E. A. Blair; Mark Vogel; Matthew E. Harinstein; Gerasimos S. Filippatos; Hani N. Sabbah; Herve Porchet; Giovanni Valentini; Mihai Gheorghiade
Publisher
Springer; Springer-Verlag; Kluwer Academic Publishers; Springer Science and Business Media LLC (ISSN 1382-4147)
Published
2009
Field
Medicine (Health Sciences)

More by Hashim Khan; Marco Metra; John E. A. Blair; Mark Vogel; Matthew E. Harinstein; Gerasimos S. Filippatos; Hani N. Sabbah; Herve Porchet; Giovanni Valentini; Mihai Gheorghiade

Browse all works by Hashim Khan; Marco Metra; John E. A. Blair; Mark Vogel; Matthew E. Harinstein; Gerasimos S. Filippatos; Hani N. Sabbah; Herve Porchet; Giovanni Valentini; Mihai Gheorghiade